(+)-L-Leucine methyl ester → HCID 22951556, 화합물

반응식

[CH:1]1[C:10]2[C:5](=[CH:6][CH:7]=[CH:8][CH:9]=2)[CH:4]=[CH:3][C:2]=1[C:11]([NH:13][C@H:14]([C:19]([OH:21])=[O:20])[C@H:15]([CH2:17][CH3:18])C)=[O:12].[CH3:22]OC(=O)[C@H](CC(C)C)N>>[CH:1]1[C:10]2[C:5](=[CH:6][CH:7]=[CH:8][CH:9]=2)[CH:4]=[CH:3][C:2]=1[C:11]([NH:13][C@H:14]([C:19]([OH:21])=[O:20])[CH2:15][CH:17]([CH3:18])[CH3:22])=[O:12]

참가 물질

반응물 2

HCID 65105(+)-L-Leucine methyl ester

HCID 30049191HCID 30049191, 화합물

생성물 1

HCID 22951556HCID 22951556, 화합물수율 98%

실험 절차

The title compound is prepared analogously is prepared similar to N-(Naphthalene-2-carbonyl)-isoleucine (see above) in 98% yield, starting from leucine methylester.

출처 및 근거

ORD 기록: ord-880e3dfbc7b043f1807e3ad819b76a55
출처 데이터셋: uspto-grants-2002_03
DOI: 10.6084/m9.figshare.5104873.v1
특허 번호: US06353017B1

반응 노트

불러오는 중…